{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:24:40Z","timestamp":1791109480795,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.jpba.2014.08.034","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T16:33:02Z","timestamp":1410021182000},"page":"25-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Development and validation of a GC\/MS method for the simultaneous determination of levetiracetam and lamotrigine in whole blood"],"prefix":"10.1016","volume":"102","author":[{"given":"Panagiota","family":"Nikolaou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Papoutsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artemisia","family":"Dona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chara","family":"Spiliopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiris","family":"Athanaselis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2014.08.034_bib0005","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/chromsci\/47.6.478","article-title":"Development and validation of a rapid column-switching high-performance liquid chromatographic method for the determination of lamotrigine in human serum","volume":"47","author":"Brunetto","year":"2009","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2014.08.034_bib0010","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1002\/rcm.2623","article-title":"Determination of levetiracetam in human plasma by liquid chromatography\/electrospray tandem mass spectrometry and its application to bioequivalence studies","volume":"20","author":"Jain","year":"2006","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2014.08.034_bib0015","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0163-7258(99)00052-2","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos","year":"2000","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2014.08.034_bib0020","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bmc.289","article-title":"High-performance liquid chromatographic determination of levetiracetam in human plasma: comparison of different sample clean-up procedures","volume":"18","author":"Pucci","year":"2004","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2014.08.034_bib0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jchromb.2010.01.037","article-title":"Quantification of levetiracetam in plasma of neonates by ultra performance liquid chromatography\u2013tandem mass spectrometry","volume":"878","author":"Blonk","year":"2010","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.034_bib0030","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1046\/j.1528-1157.2001.0420s4040.x","article-title":"Use of levetiracetam in special populations","volume":"42","author":"French","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2014.08.034_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-1211(01)00323-0","article-title":"Dose\u2013response effect of levetiracetam 1000 and 2000mg\/day in partial epilepsy","volume":"48","author":"Boon","year":"2002","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.jpba.2014.08.034_bib0040","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/chromsci\/45.9.616","article-title":"Drug monitoring: simultaneous analysis of lamotrigine, oxcarbazepine, 10-hydroxycarbazepine, and zonisamide by HPLC\u2013UV and a rapid GC method using a nitrogen-phosphorus detector for levetiracetam","volume":"45","author":"Greiner-Sosanko","year":"2007","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.jpba.2014.08.034_bib0045","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/FTD.0b013e31820b1fce","article-title":"Simultaneous quantification of levetiracetam and gabapentin in plasma by ultra-pressure liquid chromatography coupled with tandem mass spectrometry detection","volume":"33","author":"Juenke","year":"2011","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2014.08.034_bib0050","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.jpba.2014.08.034_bib0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1046\/j.1528-1157.2001.0420s4024.x","article-title":"Pharmacokinetics of levetiracetam","volume":"42","author":"Radtke","year":"2001","journal-title":"Epilepsia"},{"key":"10.1016\/j.jpba.2014.08.034_bib0060","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10895-009-0568-6","article-title":"Validated spectrofluorimetric method for the determination of lamotrigine in tablets and human plasma through derivatization with o-phthalaldehyde","volume":"20","author":"El-Enany","year":"2010","journal-title":"J. Fluoresc."},{"key":"10.1016\/j.jpba.2014.08.034_bib0065","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jchromb.2007.04.006","article-title":"Development of a simple column-switching high-performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10-monohydroxycarbazepine (MHD)","volume":"854","author":"Greiner","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.034_bib0070","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0378-4347(01)00044-5","article-title":"Lamotrigine analysis in blood and brain by high-performance liquid chromatography","volume":"755","author":"Castel-Branco","year":"2001","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.034_bib0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0378-4347(00)00102-X","article-title":"Validated high-performance liquid chromatographic method for the determination of lamotrigine in human plasma","volume":"741","author":"Barbosa","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.034_bib0080","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jpba.2008.11.030","article-title":"LC method for the therapeutic drug monitoring of lamotrigine: evaluation of the assay performance and validation of its application in the routine area","volume":"49","author":"Zufia","year":"2009","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.08.034_bib0085","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00007691-200112000-00012","article-title":"New high-performance liquid chromatographic method for plasma\/serum analysis of lamotrigine","volume":"23","author":"Croci","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2014.08.034_bib0090","unstructured":"Mayo Clinic, Mayo Medical Laboratories. Test ID: LAMO. Lamotrigine, Serum. Available at: http:\/\/www.mayomedicallaboratories.com\/test-catalog\/Clinical+and+Interpretive\/80999 (Accessed 24.07.2014)."},{"key":"10.1016\/j.jpba.2014.08.034_bib0095","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00007691-199708000-00016","article-title":"Analysis of the antiepileptic phenyltriazine compound lamotrigine using gas chromatography with nitrogen phosphorus detection","volume":"19","author":"Watelle","year":"1997","journal-title":"Ther. Drug Monit."},{"issue":"10","key":"10.1016\/j.jpba.2014.08.034_bib0100","first-page":"755","article-title":"Determination of lamotrigine, carbamazepine and carbamazepine epoxide in human serum by gas chromatography mass spectrometry","volume":"35","author":"Hallbach","year":"1997","journal-title":"Eur. J. Clin. Chem. Clin. Biochem."},{"key":"10.1016\/j.jpba.2014.08.034_bib0105","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0378-4347(00)00293-0","article-title":"Enantioselective analysis of levetiracetam and its enantiomer R-\u03b1-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection","volume":"745","author":"Isoherranen","year":"2000","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.034_bib0110","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jchromb.2005.01.040","article-title":"Determination of levetiracetam in human plasma with minimal sample pretreatment","volume":"819","author":"Martens-Lobenhoffer","year":"2005","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.034_bib0115","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/00007691-200112000-00012","article-title":"New high-performance liquid chromatographic method for plasma\/serum analysis of lamotrigine","volume":"23","author":"Croci","year":"2001","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jpba.2014.08.034_bib0120","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jchromb.2007.04.006","article-title":"Development of a simple column-switching high performance liquid chromatography (HPLC) method for rapid and simultaneous routine serum monitoring of lamotrigine, oxcarbazepine and 10-monohydroxycarbazepine (MHD)","volume":"854","author":"Greiner","year":"2007","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2014.08.034_bib0125","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpba.2011.07.018","article-title":"Development and validation of an analytical method based on high performance thin layer chromatography for the simultaneous determination of lamotrigine, zonisamide and levetiracetam in human plasma","volume":"56","author":"Antonilli","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2014.08.034_bib0130","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jpba.2011.07.019","article-title":"Simple and accurate quantitative analysis of ten antiepileptic drugs in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"56","author":"Kim","year":"2011","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"15","key":"10.1016\/j.jpba.2014.08.034_bib0135","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.4155\/bio.13.143","article-title":"A simple assay for determination of levetiracetam in rat dried blood spots by LC\u2013MS\/MS","volume":"5","author":"Luo","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2014.08.034_bib0140","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/bmc.1692","article-title":"Rapid and sensitive LC\u2013MS\/MS method for quantification of lamotrigine in human plasma: application to a human pharmacokinetic study","volume":"26","author":"Hotha","year":"2012","journal-title":"Biomed. Chromatogr."},{"key":"10.1016\/j.jpba.2014.08.034_bib0145","series-title":"Guidance for Industry, Bioanalytical Method Validation","author":"Food and Drug Administration (FDA)","year":"2001"},{"key":"10.1016\/j.jpba.2014.08.034_bib0150","series-title":"International Conference on Harmonization (ICH) of Technical requirements for Registration of Pharmaceuticals for Human Use: Harmonized Tripartite Guideline on Validation of Analytical Procedures: Text and Methodology Q2 (R1), Step 4","year":"2005"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851400418X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073170851400418X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T13:36:43Z","timestamp":1650116203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073170851400418X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":30,"alternative-id":["S073170851400418X"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2014.08.034","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of a GC\/MS method for the simultaneous determination of levetiracetam and lamotrigine in whole blood","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2014.08.034","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}